DRNA News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

Nordstrom

Powerbridge Technologies Co.

KAR Auction Services

Alfi

Reliance Steel & Aluminum

Dicerna Pharmaceuticals (DRNA) stock forecast for 2025

Last update: June 2, 2023 (09:27)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

What analysts predict: $

52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Dicerna Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Dicerna Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Dicerna Pharmaceuticals stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2025. How much will one Dicerna Pharmaceuticals share be worth in 2025? Is it worth taking profit / loss on Dicerna Pharmaceuticals stock now or waiting? What are analysts' forecasts for Dicerna Pharmaceuticals stock?

We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Dicerna Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information.

Dicerna Pharmaceuticals stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Dicerna Pharmaceuticals analysts is $.

Today 200 Day Moving Average is the support level ( $).

50 Day Moving Average is the support level ( $).

Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

Dicerna Pharmaceuticals (DRNA) Forecast for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	29.76	27.62	33.38	17.26 %
Feb	25.38	24.00	26.72	10.18 %
Mar	26.07	22.99	27.95	17.76 %
Apr	27.37	24.35	28.99	16.01 %
May	29.21	26.82	31.36	14.46 %
Jun	30.42	28.81	33.44	13.83 %
Jul	34.17	31.33	37.39	16.23 %
Aug	33.18	29.42	34.83	15.55 %
Sep	34.30	31.50	36.11	12.77 %
Oct	36.00	34.10	40.15	15.06 %
Nov	36.98	35.44	39.88	11.13 %
Dec	34.02	30.97	37.61	17.66 %

Dicerna Pharmaceuticals information and performance

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Dicerna Pharmaceuticals price target for 2025 by month

Target values for the price of one Dicerna Pharmaceuticals share for Jan 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Jan 2025 is: 29.76.
In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 17.261% volatility is expected.
Pessimistic target level: 27.62
Optimistic target level: 33.38

Target values for the price of one Dicerna Pharmaceuticals share for Feb 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Feb 2025 is: 25.38.
In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 10.182% volatility is expected.
Pessimistic target level: 24.00
Optimistic target level: 26.72

Target values for the price of one Dicerna Pharmaceuticals share for Mar 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Mar 2025 is: 26.07.
In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 17.761% volatility is expected.
Pessimistic target level: 22.99
Optimistic target level: 27.95

Target values for the price of one Dicerna Pharmaceuticals share for Apr 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Apr 2025 is: 27.37.
In Apr, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 16.012% volatility is expected.
Pessimistic target level: 24.35
Optimistic target level: 28.99

Target values for the price of one Dicerna Pharmaceuticals share for May 2025.

The weighted average target price per Dicerna Pharmaceuticals share in May 2025 is: 29.21.
In May, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 14.456% volatility is expected.
Pessimistic target level: 26.82
Optimistic target level: 31.36

Target values for the price of one Dicerna Pharmaceuticals share for Jun 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Jun 2025 is: 30.42.
In Jun, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 13.828% volatility is expected.
Pessimistic target level: 28.81
Optimistic target level: 33.44

Target values for the price of one Dicerna Pharmaceuticals share for Jul 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Jul 2025 is: 34.17.
In Jul, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 16.228% volatility is expected.
Pessimistic target level: 31.33
Optimistic target level: 37.39

Target values for the price of one Dicerna Pharmaceuticals share for Aug 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Aug 2025 is: 33.18.
In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.549% volatility is expected.
Pessimistic target level: 29.42
Optimistic target level: 34.83

Target values for the price of one Dicerna Pharmaceuticals share for Sep 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Sep 2025 is: 34.30.
In Sep, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 12.766% volatility is expected.
Pessimistic target level: 31.50
Optimistic target level: 36.11

Target values for the price of one Dicerna Pharmaceuticals share for Oct 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Oct 2025 is: 36.00.
In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.065% volatility is expected.
Pessimistic target level: 34.10
Optimistic target level: 40.15

Target values for the price of one Dicerna Pharmaceuticals share for Nov 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Nov 2025 is: 36.98.
In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 11.128% volatility is expected.
Pessimistic target level: 35.44
Optimistic target level: 39.88

Target values for the price of one Dicerna Pharmaceuticals share for Dec 2025.

The weighted average target price per Dicerna Pharmaceuticals share in Dec 2025 is: 34.02.
In Dec, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 17.656% volatility is expected.
Pessimistic target level: 30.97
Optimistic target level: 37.61

Related stocks from Healthcare sector

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.